Seminal plasma and semen amyloids enhance cytomegalovirus infection in cell culture

Journal of Virology

Volumn 87, Issue 23, 2013, Pages 12583-12591

  Tang, Qiyi ^a   Roan, Nadia R ^b   Yamamura, Yasuhiro ^a  

^a PONCE SCHOOL OF MEDICINE   (Puerto Rico)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; GLYCOPROTEIN H; NEUTRALIZING ANTIBODY; REAGENT; SEMEN AMYLOID; SEMEN DERIVED ENHANCER OF VIRAL PROTEIN; SEMENOGELIN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; SEMINAL PLASMA; VIROGENESIS; VIRUS ENTRY; VIRUS PARTICLE; VIRUS REPLICATION;

ANIMALS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; MICE; NIH 3T3 CELLS; SEMEN; SEMINAL VESICLE SECRETORY PROTEINS; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 84887201251     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02083-13     Document Type: Article

References (32)

1. Fowler KB, Pass RF. 1991. Sexually transmitted diseases in mothers of neonates with congenital cytomegalovirus infection. J. Infect. Dis. 164: 259-264.
2. Pereira L, Maidji E, Fisher SJ, McDonagh S, Tabata T. 2007. HCMV persistence in the population:potential transplacental transmission. In Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K (ed), Human herpesviruses:biology, therapy, and immunoprophylaxis. Cambridge University Press, Cambridge, United Kingdom.
3. Gianella S, Strain MC, Rought SE, Vargas MV, Little SJ, Richman DD, Spina CA, Smith DM. 2012. Associations between virologic and immunologic dynamics in blood and in the male genital tract. J. Virol. 86:1307-1315.
4. Revello MG, Gerna G. 2002. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin. Microbiol. Rev. 15:680-715.
5. Revello MG, Zavattoni M, Furione M, Lilleri D, Gorini G, Gerna G. 2002. Diagnosis and outcome of preconceptional and periconceptional primary human cytomegalovirus infections. J. Infect. Dis. 186:553-557.
6. Cannon MJ. 2009. Congenital cytomegalovirus (CMV) epidemiology and awareness. J. Clin. Virol. 46(Suppl 4):S6-S10.
7. Deayton JR, Sabin CA, Johnson MA, Emery VC, Wilson P, Griffiths PD. 2004. Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy. Lancet 363:2116-2121.
8. Mocarski ES, Jr, Shenk T, Pass RF. 2006. Cytomegaloviruses, 5th ed. Lippincott/The Williams & Wilkins Co, Philadelphia, PA.
9. Munch J, Rucker E, Standker L, Adermann K, Goffinet C, Schindler M, Wildum S, Chinnadurai R, Rajan D, Specht A, Gimenez-Gallego G, Sanchez PC, Fowler DM, Koulov A, Kelly JW, Mothes W, Grivel JC, Margolis L, Keppler OT, Forssmann WG, Kirchhoff F. 2007. Semenderived amyloid fibrils drastically enhance HIV infection. Cell 131:1059-1071.
10. Roan NR, Muller JA, Liu H, Chu S, Arnold F, Sturzel CM, Walther P, Dong M, Witkowska HE, Kirchhoff F, Munch J, Greene WC. 2011. Peptides released by physiological cleavage of semen coagulum proteins form amyloids that enhance HIV infection. Cell Host Microbe 10:541-550.
11. Wagner M, Jonjic S, Koszinowski UH, Messerle M. 1999. Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution. J. Virol. 73:7056-7060.
12. Martinez FP, Cosme RS, Tang Q. 2010. Murine cytomegalovirus major immediate-early protein 3 interacts with cellular and viral proteins in viral DNAreplication compartments and is important for early gene activation. J. Gen. Virol. 91:2664-2676.
13. Wurm M, Schambach A, Lindemann D, Hanenberg H, Standker L, Forssmann WG, Blasczyk R, Horn PA. 2010. The influence of semenderived enhancer of virus infection on the efficiency of retroviral gene transfer. J. Gene Med. 12:137-146.
14. Tang Q, Li L, Maul GG. 2005. Mouse cytomegalovirus early M112/113 proteins control the repressive effect of IE3 on the major immediate-early promoter. J. Virol. 79:257-263.
15. Loh LC, Keeler VD, Shanley JD. 1999. Sequence requirements for the nuclear localization of the murine cytomegalovirus M44 gene product pp50. Virology 259:43-59.
16. Wu CA, Carlson ME, Henry SC, Shanley JD. 1999. The murine cytomegalovirus m25 open reading frame encodes a component of the tegument. Virology 262:265-276.
17. Roan NR, Munch J, Arhel N, Mothes W, Neidleman J, Kobayashi A, Smith-McCune K, Kirchhoff F, Greene WC. 2009. The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection. J. Virol. 83:73-80.
18. Yolamanova M, Meier C, Shaytan AK, Vas V, Bertoncini CW, Arnold F, Zirafi O, Usmani SM, Muller JA, Sauter D, Goffinet C, Palesch D, Walther P, Roan NR, Geiger H, Lunov O, Simmet T, Bohne J, Schrezenmeier H, Schwarz K, Standker L, Forssmann WG, Salvatella X, Khalatur PG, Khokhlov AR, Knowles TP, Weil T, Kirchhoff F, Munch J. 2013. Peptide nanofibrils boost retroviral gene transfer and provide a rapid means for concentrating viruses. Nat. Nanotechnol. 8:130-136.
19. Perez KJ, Martinez FP, Cosme-Cruz R, Perez-Crespo NM, Tang Q. 2013. A short cis-acting motif in the M112-113 promoter region is essential for IE3 to activate M112-113 gene expression and is important for murine cytomegalovirus replication. J. Virol. 87:2639-2647.
20. Kim KA, Yolamanova M, Zirafi O, Roan NR, Staendker L, Forssmann WG, Burgener A, Dejucq-Rainsford N, Hahn BH, Shaw GM, Greene WC, Kirchhoff F, Munch J. 2010. Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI. Retrovirology 7:55.
21. Compton T, Feire A. 2007. Early events in human cytomegalovirus infection. Chapter 16. In Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K (ed), Human herpesviruses:biology, therapy, and immunoprophylaxis. Cambridge University Press, Cambridge, United Kingdom.
22. Britt WJ, Vugler L, Butfiloski EJ, Stephens EB. 1990. Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB):use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response. J. Virol. 64:1079-1085.
23. Crumpacker CS, Zhang J. 2009. Cytomegalovirus, p 1971-1989. In Mandell GL, Bennett JE, Dolin R (ed), Principles and practice of infectious diseases, 6th ed. Churchill Livingstone, New York, NY.
24. Walker SP, Palma-Dias R, Wood EM, Shekleton P, Giles ML. 2013. Cytomegalovirus in pregnancy:to screen or not to screen. BMC Pregnancy Childbirth 13:96. doi:10.1186/1471-2393-13-96.
25. Griffiths P. 2004. Cytomegalovirus infection of the central nervous system. Herpes 11(Suppl 2):95A-104A.
26. Gianella S, Anderson CM, Vargas MV, Richman DD, Little SJ, Morris SR, Smith DM. 2013. Cytomegalovirus DNA in semen and blood is associated with higher levels of proviral HIV DNA. J. Infect. Dis. 207:898-902.
27. Roan NR, Sowinski S, Munch J, Kirchhoff F, Greene WC. 2010. Aminoquinoline surfen inhibits the action of SEVI (semen-derived enhancer of viral infection). J. Biol. Chem. 285:1861-1869.
28. Maidji E, McDonagh S, Genbacev O, Tabata T, Pereira L. 2006. Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis. Am. J. Pathol. 168: 1210-1226.
29. McDonagh S, Maidji E, Chang HT, Pereira L. 2006. Patterns of human cytomegalovirus infection in term placentas:a preliminary analysis. J. Clin. Virol. 35:210-215.
30. Wang D, Shenk T. 2005. Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. Proc. Natl. Acad. Sci. U.S.A. 102:18153-18158.
31. Li L, Coelingh KL, Britt WJ. 1995. Human cytomegalovirus neutralizing antibody-resistant phenotype is associated with reduced expression of glycoprotein H. J. Virol. 69:6047-6053.
32. Gianella S, Mehta SR, Strain MC, Young JA, Vargas MV, Little SJ, Richman DD, Kosakovsky Pond SL, Smith DM. 2012. Impact of seminal cytomegalovirus replication on HIV-1 dynamics between blood and semen. J. Med. Virol. 84:1703-1709.